← Evidence map

ReviewBreathe (Sheffield, England)2021

Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy.

Gokul Erumbala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35035570